SALIX PHARMACEUTICALS, INC.: Salix Provides Update on FDA Submission for PLENVU®

Salix Pharmaceuticals, Ltd., one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases and a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. have received notice that the U.S. Food and Drug Administration has extended the PDUFA action date for its review of the New Drug Application for PLENVU®* (NER1006) by three months to May 13, 2018. Read More »

Xerox changes direction on Medicaid management platform in California, Montana

Xerox issued an update Oct. 13 on the strategic direction of its government health care business, focusing the implementation of its Health Enterprise Medicaid platform in California and Montana.Based on discussions with clients in California and Montana, Xerox said is likely it will not fully complete the implementation of the Health Enterprise Medicaid platform, its next-generation Medicaid Management Information System, in these states. Xerox said it expects to continue to process Medicaid cl Read More »